Category: JNJ
-
Jennifer Taubert, EVP of Innovative Medicine, Sells 15,000 Shares at JNJ
Jennifer L. Taubert, Executive Vice President of Worldwide Commercial at Johnson & Johnson, executed an open market sale of 15,000 shares on August 17, 2026, at an average price of $263.36 per share. This transaction, valued at approximately $3.95 million, reduces her beneficial ownership to 209,451 shares. Taubert’s sale was conducted under a pre-arranged Rule…
Energy
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
